Literature DB >> 31267156

NMDA receptor antagonists traxoprodil and lanicemine improve hippocampal-prefrontal coupling and reward-related networks in rats.

Robert Becker1, Natalia Gass2, Lothar Kußmaul3, Bernhard Schmid3, Stefan Scheuerer3, David Schnell3, Cornelia Dorner-Ciossek3, Wolfgang Weber-Fahr2, Alexander Sartorius2,4.   

Abstract

RATIONALE: The N-methyl-D-aspartate receptor (NMDAR) antagonist ketamine is known to have not only a rapid antidepressant effect but also dissociative side effects. Traxoprodil and lanicemine, also NMDA antagonists, are candidate antidepressant drugs with fewer side effects.
OBJECTIVES: In order to understand their mechanism of action, we investigated the acute effects of traxoprodil and lanicemine on brain connectivity using resting-state functional magnetic resonance imaging (rs-fMRI).
METHODS: Functional connectivity (FC) alterations were examined using interregional correlation networks. Graph theoretical methods were used for whole brain network analysis. As interest in NMDAR antagonists as potential antidepressants was triggered by the antidepressant effect of ketamine, results were compared to previous findings from our ketamine studies.
RESULTS: Similar to ketamine but to a smaller extent, traxoprodil increased hippocampal-prefrontal (Hc-PFC) coupling. Unlike ketamine, traxoprodil decreased connectivity within the PFC. Lanicemine had no effect on these properties. The improvement of Hc-PFC coupling corresponds well to clinical result, showing ketamine to have a greater antidepressant effect than traxoprodil, while lanicemine has a weak and transient effect. Connectivity changes overlapping between the drugs as well as alterations of local network properties occurred mostly in reward-related regions.
CONCLUSION: The antidepressant effect of NMDA antagonists appears to be associated with enhanced Hc-PFC coupling. The effects on local network properties and regional connectivity suggest that improvement of reward processing might also be important for understanding the mechanisms underlying the antidepressant effects of these drugs.

Entities:  

Keywords:  Hippocampal-prefrontal coupling; NMDA antagonists; Networks; fMRI

Mesh:

Substances:

Year:  2019        PMID: 31267156     DOI: 10.1007/s00213-019-05310-3

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  49 in total

1.  Antagonism at the NR2B subunit of NMDA receptors induces increased connectivity of the prefrontal and subcortical regions regulating reward behavior.

Authors:  Natalia Gass; Robert Becker; Markus Sack; Adam J Schwarz; Jonathan Reinwald; Alejandro Cosa-Linan; Lei Zheng; Christian Clemm von Hohenberg; Dragos Inta; Andreas Meyer-Lindenberg; Wolfgang Weber-Fahr; Peter Gass; Alexander Sartorius
Journal:  Psychopharmacology (Berl)       Date:  2018-01-05       Impact factor: 4.530

2.  Antidepressant effects of ketamine in depressed patients.

Authors:  R M Berman; A Cappiello; A Anand; D A Oren; G R Heninger; D S Charney; J H Krystal
Journal:  Biol Psychiatry       Date:  2000-02-15       Impact factor: 13.382

3.  Visual inspection of independent components: defining a procedure for artifact removal from fMRI data.

Authors:  Robert E Kelly; George S Alexopoulos; Zhishun Wang; Faith M Gunning; Christopher F Murphy; Sarah Shizuko Morimoto; Dora Kanellopoulos; Zhiru Jia; Kelvin O Lim; Matthew J Hoptman
Journal:  J Neurosci Methods       Date:  2010-04-08       Impact factor: 2.390

4.  Enhanced default mode network connectivity with ventral striatum in subthreshold depression individuals.

Authors:  J W Hwang; S C Xin; Y M Ou; W Y Zhang; Y L Liang; J Chen; X Q Yang; X Y Chen; T W Guo; X J Yang; W H Ma; J Li; B C Zhao; Y Tu; J Kong
Journal:  J Psychiatr Res       Date:  2016-02-13       Impact factor: 4.791

5.  Absolute oral bioavailability of traxoprodil in cytochrome P450 2D6 extensive and poor metabolisers.

Authors:  Timothy J Taylor; Kelly Diringer; Tanya Russell; Karthik Venkatakrishnan; Keith Wilner; Penelope H Crownover; Lisa J Benincosa; Megan A Gibbs
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

6.  Mapping the central effects of (±)-ketamine and traxoprodil using pharmacological magnetic resonance imaging in awake rats.

Authors:  Haiying Tang; Daniel Kukral; Yu-Wen Li; Matthew Fronheiser; Harold Malone; Adrienne Pena; Rick Pieschl; Kurex Sidik; Gabriel Tobon; Patrick L Chow; Linda J Bristow; Wendy Hayes; Feng Luo
Journal:  J Psychopharmacol       Date:  2018-01-30       Impact factor: 4.153

7.  Increased Default Mode Network Connectivity in Individuals at High Familial Risk for Depression.

Authors:  Jonathan Posner; Jiook Cha; Zhishun Wang; Ardesheer Talati; Virginia Warner; Andrew Gerber; Bradley S Peterson; Myrna Weissman
Journal:  Neuropsychopharmacology       Date:  2015-11-23       Impact factor: 7.853

Review 8.  The hippocampal-prefrontal pathway: the weak link in psychiatric disorders?

Authors:  Bill P Godsil; Janos P Kiss; Michael Spedding; Thérèse M Jay
Journal:  Eur Neuropsychopharmacol       Date:  2013-01-15       Impact factor: 4.600

9.  Disrupted reward circuits is associated with cognitive deficits and depression severity in major depressive disorder.

Authors:  Liang Gong; Yingying Yin; Cancan He; Qing Ye; Feng Bai; Yonggui Yuan; Haisan Zhang; Luxian Lv; Hongxing Zhang; Chunming Xie; Zhijun Zhang
Journal:  J Psychiatr Res       Date:  2016-09-17       Impact factor: 4.791

10.  Olfactory tubercle stimulation alters odor preference behavior and recruits forebrain reward and motivational centers.

Authors:  Brynn J Fitzgerald; Kara Richardson; Daniel W Wesson
Journal:  Front Behav Neurosci       Date:  2014-03-14       Impact factor: 3.558

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.